Manini, C.; González, A.; Büchser, D.; GarcÃa-Olaverri, J.; Urresola, A.; Ezquerro, A.; Fernández, I.; Llarena, R.; Zabalza, I.; Pulido, R.;
et al. Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. J. Pers. Med. 2020, 10, 265.
https://doi.org/10.3390/jpm10040265
AMA Style
Manini C, González A, Büchser D, GarcÃa-Olaverri J, Urresola A, Ezquerro A, Fernández I, Llarena R, Zabalza I, Pulido R,
et al. Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. Journal of Personalized Medicine. 2020; 10(4):265.
https://doi.org/10.3390/jpm10040265
Chicago/Turabian Style
Manini, Claudia, Alba González, David Büchser, Jorge GarcÃa-Olaverri, Arantza Urresola, Ana Ezquerro, Iratxe Fernández, Roberto Llarena, Iñaki Zabalza, Rafael Pulido,
and et al. 2020. "Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer" Journal of Personalized Medicine 10, no. 4: 265.
https://doi.org/10.3390/jpm10040265
APA Style
Manini, C., González, A., Büchser, D., GarcÃa-Olaverri, J., Urresola, A., Ezquerro, A., Fernández, I., Llarena, R., Zabalza, I., Pulido, R., Carracedo, A., Gómez-Iturriaga, A., & López, J. I.
(2020). Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer. Journal of Personalized Medicine, 10(4), 265.
https://doi.org/10.3390/jpm10040265
